Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children

Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in... Key PointsQuestionDo atropine, 0.01%, eyedrops slow the myopia progression and axial elongation when compared with a placebo group in Chinese children? FindingsIn this randomized clinical trial, atropine, 0.01%, eyedrops reduced myopia progression and axial elongation compared with placebo treatment after 1 year. MeaningWhile the clinical relevance of the results cannot be determined from this trial, these results support the potential that atropine, 0.01%, eyedrops can slow myopia progression in Chinese children and warrant future studies to determine longer-term results and potential effects on slowing sight-threatening pathologic changes later in life. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children

Loading next page...
 
/lp/american-medical-association/safety-and-efficacy-of-low-dose-atropine-eyedrops-for-the-treatment-of-obDDC2iVRy
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2020.3820
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionDo atropine, 0.01%, eyedrops slow the myopia progression and axial elongation when compared with a placebo group in Chinese children? FindingsIn this randomized clinical trial, atropine, 0.01%, eyedrops reduced myopia progression and axial elongation compared with placebo treatment after 1 year. MeaningWhile the clinical relevance of the results cannot be determined from this trial, these results support the potential that atropine, 0.01%, eyedrops can slow myopia progression in Chinese children and warrant future studies to determine longer-term results and potential effects on slowing sight-threatening pathologic changes later in life.

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Nov 1, 2020

References